According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5,355.79, which grew from USD 3,515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.
Increase in Bio Pharmacy Industry – As per IFPMA 23 biopharmaceutical companies, in July 2020 partnered with non-governmental stakeholders to develop 4 novel antibiotics by launching USD 1 billion AMR (Anti-Microbial Resistance) Action Fund.
Rising Use of Vaccines- According to Our World in Data 67.4% of the world population has received one dose of the COVID-19 vaccine. Globally, 12.47 billion doses have been administered and 5.05 million are now being administered each day.
Increase in Research Labs - As per aggregate estimates of about 60 companies, the investment of the private sector for R&D dedicated to AMR-related products was more than USD 2 billion in 2018.
Rise of COVID-19 – The COVID-19 vaccine output reached about 13 billion doses by the end of 2021 and is estimated to reach 25 billion by mid-2022.
Increase Deaths from Contaminated Products – Nitrosamines, potent carcinogens are found as an impurity in medications such as ranitidine, nizatidine, ARBs, metformin, and other OTC drugs.
The global disposable aseptic isolation systems market is segmented and analyzed for demand and supply by end-user into pharmaceutical companies, hospitals, chemical industry, research institutes, biosafety laboratories, and others. Out of which, the pharmaceutical companies segment is anticipated to hold the largest market size by the end of 2031 on account of growing demand for pharmaceutical isolators in the pharmaceutical and biotechnological industries during the forecast period. Moreover, the increasing regulations, usage of aseptic methods, growing research laboratories, cost of noncompliance, rising usage of harmful materials, and advancements in the efficiency of isolators are expected to be major growth factors. The research and development expenditure (in GDP %) in 2021 amounted to 2.63% up from 2.13% in 2017.
Regionally, the global disposable aseptic isolation systems market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America region is projected to hold the largest market share by the end of 2031. Moreover, the growth of the market is attributed on the back of the great hold in the dominating position of the manufacturing industry, the adoption of disposable aseptic isolation systems in the field of biopharmaceuticals, and the rise of investment in medicines and healthcare. As per the IFMA report 2021, the global spending of the United States on medicines will increase from USD 485 billion in 2018 to USD 625-655 billion in 2023.
Get more information on this report: Request Sample PDF
The global disposable aseptic isolation systems market is further classified on the basis of region as follows:
Our in-depth analysis of the global disposable aseptic isolation systems market includes the following segments:
Berkshire Sterile Manufacturing introduced a new technology to decontaminate RTU tubs for sterility assurance during filling operations thereby reducing the risk of contamination.
Getinge AB provides at-home care for cancer patients in coordination with Sciensus. They together made GMP ISOFLEX-R aseptic isolators with a DPTE transfer system that uses RTP or alpha-beta transfer port with no leakage and risk-free connectivity.
In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.
Author Credits: Radhika Gupta, Shivam Bhutani
Ans: Increase in bio pharmacy industry, rising use of vaccines, and increase in research labs are the major factors driving the growth of the disposable aseptic isolation systems market.
Ans: The market is anticipated to attain a CAGR of ~6% over the forecast period, i.e., 2022 – 2031.
Ans: Higher purchase costs and limited flexibility are the challenges affecting the market growth.
Ans: The market in North America region is projected to hold the largest market share by the end of 2031 and provide more business opportunities in the future.
Ans: The major players in the market are Arjo, Famed Zywiec Sp. z o. o., GF Health Products, Inc., Getinge AB, Hillrom Company Inc., Invacare Corporation, LINET spol.s r.o., Malvestio Spa, Merivaara, Midmark Corporation.
Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
Ans: The market is segmented by type, application, end-user, and by region.
Ans: The pharmaceutical companies segment is anticipated to garner the largest market size by the end of 2031 and display significant growth opportunities.